skip
net ir
Japanese

Santen Pharmaceutical Co., Ltd.

code | 4536Market | TYO1Category of Business | Pharmaceuticals
Inquiry : 4-20 Ofuka-cho, Kita-ku, Osaka 533-8651 [Official Homepage]
TEL : 06-6321-7000


Corporate Presentation

2018/05/11
Investor Meeting on FY2017 Results and FY2018 Forecasts
Chairman & Chief Executive Officer (CEO) Akira Kurokawa
President & Chief Operating Officer (COO) Shigeo Taniuchi
Senior Corporate Officer Chief Scientific Officer (CSO) Head of Global Research & Development Naveed Shams,M.D.,Ph.D.
Presentation material(PDF:1098KB)
300k
2018/03/02
Japan and Asia Business Update
President & CEO Akira Kurokawa
Member of the Board,Executive Corporate Officer, Japan Business,Head of Japan Sales and Marketing, Prescription Pharmaceuticals Takeshi Ito
Corporate Officer General Manager Santen Pharmaceutical (China) Co., Ltd. Ye Liu
Presentation material(PDF:3791KB)
300k
2017/11/06
Investor Meeting on Q2 FY2017 Results
Naveed Shams,Ph.D. Senior Corporate Officer Chief Scientific Officer (CSO) Head of Global Research & Development
Kazuo Koshiji Chief Financial Officer (CFO),Head of Finance and Administration Division
Chris Hoffman General manager,Corporate Communication

Akira Kurokawa President & CEO
Presentation material (PDF:904KB)
300k
2017/05/12
Investor Meeting on FY2016 Results and FY2017 Forecasts
Akira Kurokawa President & CEO
Naveed Shams,Ph.D. Senior Corporate Officer Chief Scientific Officer (CSO) Head of Global Research & Development Naveed
Kazuo Koshiji Chief Financial Officer (CFO),Head of Finance and Administration Division
Chris Hoffman General manager,Corporate Communication
Presentation material(PDF:1113KB)
300k




Precautions in use
Nomura IR assumes no responsibility for correctness, validity or any other nature of the contents on this server.
No act such as alteration, modification or addition to the contents is permitted.
Since the contents on this server are not intended to solicit investment, our company has no liability for any trouble related to investment made by any audience based on the contents of this site. Investors are required to decide at their own discretion.
Nomura IR assumes no responsibility for correctness, validity or any other nature of information, including its format and details, obtained from any site linked from our site.

up
Download Plug-in
Get Adobe Reader
Windows Media Player
Real Player
Copyright (c) 2004 Nomura Investor Relations Co., Ltd. All Rights Reserved.
NIR